Sweden
· Delayed Price · Currency is SEK MAGLE Company Description
Magle Chemoswed Holding AB (publ), together with its subsidiaries, operates as a contract development and manufacturing organization that serves pharmaceutical and medical device industry on a contract basis in Sweden.
It provides warfarin sodium products used as anticoagulants for multiple indications; melperone hydrochloride, which is an antipsychotic agent; isradipine, a calcium channel blocker used to treat hypertension; amantadine sulfate that is used in the treatment of central nervous system disorders; and benserazide hydrochloride, which is used in combination with L-Dopa in the treatment of Parkinson’s disease.
The company also offers EmboCept S, a microsphere-based medical device used in vascular occlusion of liver and lung tumors; SmartGel, a non-allergenic hydrogel based on the company’s microsphere technology; and SmartPAN, a medical device for the detection of pancreatic fluid leakage during open or minimally invasive surgical procedures.
In addition, it is developing EmboCept M for the treatment of benign prostatic hyperplasia; EmboCept L for the treatment of uterine fibroids; SmartGel II, an advanced wound care hydrogel for the removal and prevention of wound biofilm; and SmartBone, an advanced formulation of microspheres in combination with active ingredients for stimulation of bone growth in surgical implant procedures.
The company was founded in 1944 and is based in Malmö, Sweden. Magle Chemoswed Holding AB (publ) is a subsidiary of Magle AB.
| Country | Sweden |
| Founded | 1944 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 78 |
| CEO | Justin Pierce |
Contact Details
Address: AgneslundsvAegen 27 Malmö, 212 15 Sweden | |
| Phone | 46 7 61 64 33 12 |
| Website | maglechemoswed.com |
Stock Details
| Ticker Symbol | MAGLE |
| Exchange | Nasdaq Stockholm |
| Fiscal Year | January - December |
| Reporting Currency | SEK |
| ISIN Number | SE0014401014 |
| SIC Code | 2833 |
Key Executives
| Name | Position |
|---|---|
| Justin Pierce | Chief Executive Officer |
| Hans Henrik Lidgard | Founder and Chairman |
| Petra Jonsson Sjolin | Chief Financial Officer |
| Fredrik Andersson | Chief Operations Officer |
| Megi Medzmariashvili | Legal Counsel |
| Helena Ossmer Thedius | Chief Marketing and Innovation Officer |
| Simon Jegou | Chief Strategy Officer |